Cargando…
The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
B-cell precursor acute lyphoblastic leukemia (ALL) is a common pediatric malignancy and patients may have significant benefits from monoclonal antibodies therapy with increased survival rates. Positive CD20 expression is identified in about half of these patients and its presence may serve as a prog...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961970/ https://www.ncbi.nlm.nih.gov/pubmed/36835986 http://dx.doi.org/10.3390/jcm12041451 |
_version_ | 1784895887494873088 |
---|---|
author | Serbanica, Andreea Nicoleta Popa, Delia Codruta Caruntu, Constantin Pasca, Sergiu Scheau, Cristian Serbanica, Ionut Vlad Suciu, Raluca Tica, Valeria Busescu, Elisa Cima, Luminita Nicoleta Jardan, Cerasela Dragomir, Mihaela Coriu, Daniel Colita, Andrei Colita, Anca |
author_facet | Serbanica, Andreea Nicoleta Popa, Delia Codruta Caruntu, Constantin Pasca, Sergiu Scheau, Cristian Serbanica, Ionut Vlad Suciu, Raluca Tica, Valeria Busescu, Elisa Cima, Luminita Nicoleta Jardan, Cerasela Dragomir, Mihaela Coriu, Daniel Colita, Andrei Colita, Anca |
author_sort | Serbanica, Andreea Nicoleta |
collection | PubMed |
description | B-cell precursor acute lyphoblastic leukemia (ALL) is a common pediatric malignancy and patients may have significant benefits from monoclonal antibodies therapy with increased survival rates. Positive CD20 expression is identified in about half of these patients and its presence may serve as a prognostic factor in disease evolution. We performed a retrospective study including 114 patients diagnosed with B-ALL and evaluated the expression of CD20 through flow cytometry at diagnosis and on day 15. Additional immunophenotypic analyses as well as cytogenetic and molecular genetic analyses were also performed. We observed an increase in the mean fluorescence intensity (MFI) of CD20 between diagnosis—1.9 (1.2–3.26) and day 15: 6.17 (2.14–27.4), (p < 0.0001). Furthermore, we assessed that both diagnosis and day 15 CD20 MFI had an impact on RFS and OS, respectively, for cut-off values of >8.08 at diagnosis and >28.65 at day 15. In conclusion, CD20 expression appears to be a poor prognostic feature of B-ALL in pediatric patients. In this study, stratification of the outcome by the intensity of CD20 has implications concerning the allocation to rituximab-based chemotherapy and may offer new, potentially useful information for pediatric patients with B-ALL. |
format | Online Article Text |
id | pubmed-9961970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99619702023-02-26 The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia Serbanica, Andreea Nicoleta Popa, Delia Codruta Caruntu, Constantin Pasca, Sergiu Scheau, Cristian Serbanica, Ionut Vlad Suciu, Raluca Tica, Valeria Busescu, Elisa Cima, Luminita Nicoleta Jardan, Cerasela Dragomir, Mihaela Coriu, Daniel Colita, Andrei Colita, Anca J Clin Med Article B-cell precursor acute lyphoblastic leukemia (ALL) is a common pediatric malignancy and patients may have significant benefits from monoclonal antibodies therapy with increased survival rates. Positive CD20 expression is identified in about half of these patients and its presence may serve as a prognostic factor in disease evolution. We performed a retrospective study including 114 patients diagnosed with B-ALL and evaluated the expression of CD20 through flow cytometry at diagnosis and on day 15. Additional immunophenotypic analyses as well as cytogenetic and molecular genetic analyses were also performed. We observed an increase in the mean fluorescence intensity (MFI) of CD20 between diagnosis—1.9 (1.2–3.26) and day 15: 6.17 (2.14–27.4), (p < 0.0001). Furthermore, we assessed that both diagnosis and day 15 CD20 MFI had an impact on RFS and OS, respectively, for cut-off values of >8.08 at diagnosis and >28.65 at day 15. In conclusion, CD20 expression appears to be a poor prognostic feature of B-ALL in pediatric patients. In this study, stratification of the outcome by the intensity of CD20 has implications concerning the allocation to rituximab-based chemotherapy and may offer new, potentially useful information for pediatric patients with B-ALL. MDPI 2023-02-11 /pmc/articles/PMC9961970/ /pubmed/36835986 http://dx.doi.org/10.3390/jcm12041451 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Serbanica, Andreea Nicoleta Popa, Delia Codruta Caruntu, Constantin Pasca, Sergiu Scheau, Cristian Serbanica, Ionut Vlad Suciu, Raluca Tica, Valeria Busescu, Elisa Cima, Luminita Nicoleta Jardan, Cerasela Dragomir, Mihaela Coriu, Daniel Colita, Andrei Colita, Anca The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia |
title | The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia |
title_full | The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia |
title_fullStr | The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia |
title_full_unstemmed | The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia |
title_short | The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia |
title_sort | significance of cd20 intensity variance in pediatric patients with b-cell precursor acute lymphoblastic leukemia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961970/ https://www.ncbi.nlm.nih.gov/pubmed/36835986 http://dx.doi.org/10.3390/jcm12041451 |
work_keys_str_mv | AT serbanicaandreeanicoleta thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT popadeliacodruta thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT caruntuconstantin thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT pascasergiu thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT scheaucristian thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT serbanicaionutvlad thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT suciuraluca thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT ticavaleria thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT busescuelisa thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT cimaluminitanicoleta thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT jardancerasela thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT dragomirmihaela thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT coriudaniel thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT colitaandrei thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT colitaanca thesignificanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT serbanicaandreeanicoleta significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT popadeliacodruta significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT caruntuconstantin significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT pascasergiu significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT scheaucristian significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT serbanicaionutvlad significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT suciuraluca significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT ticavaleria significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT busescuelisa significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT cimaluminitanicoleta significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT jardancerasela significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT dragomirmihaela significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT coriudaniel significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT colitaandrei significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia AT colitaanca significanceofcd20intensityvarianceinpediatricpatientswithbcellprecursoracutelymphoblasticleukemia |